HMG-CoA Reductase Inhibitor

Established Pharmacologic Class (EPC) Comparison, United States, 2023

Total Prescriptions in (2023)

Drug Name Total Prescriptions (2023) Percent Share
Atorvastatin 115,271,515 58.4%
Rosuvastatin 42,103,430 21.3%
Simvastatin 24,585,762 12.5%
Pravastatin 11,060,711 5.6%
Lovastatin 4,392,660 2.2%

Total Prescriptions by Drug Over Time

Drug Class Prescribing Trends Over Time


Prescription data source: Medical Expenditure Panel Survey (MEPS) 2014-2023. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 2025.08. Read more about the ClinCalc DrugStats database.

All ClinCalc DrugStats figures and graphs on this page are licensed under Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0).

Search

Related Links

Mailing List

New and Popular

Loading...

Open Menu

Cite This Page

Show AMA citation

Biostatistics Rx - FREE YOUR MIND - Unlock the matrix of learning biostats and analyzing clinical trials
 
©2025 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Sep 12, 2021
Back to Top
Top